AXLRx is a custom-built commercial consulting engine for pharma: evidence-led answers to the commercial questions that move your decision. Every figure is verified against a live source. Delivered in 72 hours.
You are not buying an off-the-shelf report. Every brand decision sits in one of four commercial stages, each answering a single buyer question, each scoped to your asset. The report types live inside them.
Not prose about the market. Built exhibits, scoped to your asset, that a commercial team can decide on. Every figure carries its source.
| Agent | Class | MASH Res. | Share |
|---|---|---|---|
| Rezdiffra | THR-β | 62.9% | ~40% |
| Zepbound | GIP/GLP-1 | Off-label | ~12% |
| Your asset | TBD | — | Ex.3 |
AXLRx uses none of its own memory as a source. Every figure clears these checks before it reaches you. If it cannot be sourced, it does not ship.
Every claim is cited to a live PMID, ClinicalTrials.gov ID or URL at the point of writing. Uncited claims are dropped, not estimated.
The figure must appear in the cited source, not merely be consistent with it. Metadata is fetched live, never recalled.
A separate pass re-checks every link, claim and number before delivery. One dropped figure is one too many.
Not a generic AI tool, and not a syndicated PDF. A custom-built consulting engine, run by pharma practitioners, that answers the question in front of you.
Each report type encodes a real pharma commercial-intelligence process, not a generic prompt chain.
Cited to a live PMID, trial ID or URL at the point of writing. Defensible the moment you present it.
Scoped to your asset and proposed label, framing the decision — not describing the category in aggregate.
Adapted to the exact question, comparators and market in front of you. No two reports are the same.
Methodology from former IQVIA, L.E.K. and MNC commercial teams, on 20 years of pharma practice.
No seat licence, no dashboard to operate. The finished deliverable lands on your desk in 72 hours.
Pharma CI, market access and launch analysis.
AXLRx is built by MoatRx, a pharma strategy and analytics consultancy working across GCC and global markets.
About the team →Scope confirmed in 24 hours. Delivered in 72 hours. Every figure put in front of a payer.